Loading insider details...
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 614 MNPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 614 | n/a |
| Jul 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,228 | n/a |
| Dec 29, 2025 | Monopar Therapeutics (MNPR) | Purchase | 1,500 | $104.9K |
| Dec 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 7,135 | n/a |
| Mar 5, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 25,000 | n/a |
| Dec 16, 2021 | 180 Life Sciences Corp. (ATNF) | Purchase | 8,000 | $31.8K |
| Dec 10, 2021 | 180 Life Sciences Corp. (ATNF) | Purchase | 4,500 | $17.6K |
| Dec 10, 2021 | 180 Life Sciences Corp. (ATNF) | Grant/Award | 275,000 | n/a |